Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Prednisolone - Generic Drug Details

« Back to Dashboard

What are the generic sources for prednisolone and what is the scope of prednisolone freedom to operate?

is the generic ingredient in thirty-eight branded drugs marketed by Hi Tech Pharma Co, Halsey, Marshall Pharma, Schering, Pvt Form, Wockhardt, Watson Labs, Teva Pharms, Phoenix Labs Ny, Nesher Pharms, Vistapharm, West Ward, Elkins Sinn, Purepac Pharm, Barr, Heather, Roxane, Lannett, Vitarine, Valeant Pharm Intl, Everylife, Sandoz, Ferndale Labs, Chartwell Rx, Whiteworth Town Plsn, Inwood Labs, Panray, Muro, Sperti, Ferrante, Apotex Inc, Tablicaps, Aurolife Pharma Llc, Vintage, Bundy, Ivax Sub Teva Pharms, Impax Labs, Teva, Pharmacia And Upjohn, UDL, We Pharms, Superpharm, Pfizer, Pharm Assoc, Allergan, Cent Pharms, Akorn, Bel Mar, Taro, Alcon, Novartis Pharms Corp, Pharmafair, Bausch And Lomb, Novartis, Vintage Pharms, Concordia Pharms Inc, Merck, Alcon Pharms Ltd, Amneal Pharms, Medicis Pharms, Seton Pharm, Edenbridge Pharms, Sola Barnes Hind, Mylan Pharms Inc, Hi Tech Pharma, Paddock Llc, Mission Pharma, and Sandoz Inc, and is included in one hundred and twenty-one NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighty-five drug master file entries for prednisolone. Eighteen suppliers are listed for this compound.

Summary for Generic Name: prednisolone

Drug Master File Entries: see list85
Suppliers / Packagers: see list18
Bulk Api Vendors: see list51
Clinical Trials: see list149
Patent Applications: see list7,014
Therapeutic Class:Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:prednisolone at DailyMed

Pharmacology for Ingredient: prednisolone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sola Barnes Hind
prednisolone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC084171-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Elkins Sinn
TABLET;ORAL080625-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
prednisolone acetate; sulfacetamide sodium
SUSPENSION/DROPS;OPHTHALMIC088059-001Jul 29, 1983DISCNNoNo► Subscribe► Subscribe
TABLET;ORAL085170-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
TABLET;ORAL085416-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus